Small Molecules

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.

US Senator Elizabeth Warren calls for a federal investigation into GSK and its discontinuation of Flovent HFA

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction.

The Access to Medicine Foundation has developed the 2026 AMR Benchmark to recognize and promote urgency in the ongoing AMR challenge.

Oral solid dosage, HPAPIs, OSD development, OSD formulations, poorly soluble drugs, fixed-dose combinations, controlled release

Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

So much has already been achieved with RNA – and it’s only going to get better.

Why mRNA will be a key disrupter in the coming years; experts from CureVac and Omega Therapeutics give their views.